These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7734108)

  • 41. Pharmacology and regulation of the neuronal dopamine transporter.
    Reith ME; Xu C; Chen NH
    Eur J Pharmacol; 1997 Apr; 324(1):1-10. PubMed ID: 9137907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parkinsonism-inducing neurotoxin MPP+: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA.
    Kitayama S; Shimada S; Uhl GR
    Ann Neurol; 1992 Jul; 32(1):109-11. PubMed ID: 1642464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons.
    Nirenberg MJ; Vaughan RA; Uhl GR; Kuhar MJ; Pickel VM
    J Neurosci; 1996 Jan; 16(2):436-47. PubMed ID: 8551328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the protective effects of 21-aminosteroids in MPP(+)-induced neurotoxicity to dopaminergic neurons in mesencephalic cultures.
    Sanchez-Ramos JR; Song S; Oppenheimer J; Mash D; Weiner WJ
    Ann N Y Acad Sci; 1992 May; 648():338-9. PubMed ID: 1637065
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transporters.
    Koutsilieri E; Kornhuber J; Degen HJ; Lesch KP; Sopper S; ter Meulen V; Riederer P
    J Neurosci Res; 1996 Aug; 45(3):269-75. PubMed ID: 8841987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport.
    Fountaine TM; Wade-Martins R
    J Neurosci Res; 2007 Feb; 85(2):351-63. PubMed ID: 17131421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cognate dopamine transporter-like activity endogenously expressed in a COS-7 kidney-derived cell line.
    Sugamori KS; Lee FJ; Pristupa ZB; Niznik HB
    FEBS Lett; 1999 May; 451(2):169-74. PubMed ID: 10371159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-methyl-(R)salsolinol as a dopaminergic neurotoxin: from an animal model to an early marker of Parkinson's disease.
    Naoi M; Maruyama W; Dostert P; Hashizume Y
    J Neural Transm Suppl; 1997; 50():89-105. PubMed ID: 9120428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage.
    Prasad BM; Amara SG
    J Neurosci; 2001 Oct; 21(19):7561-7. PubMed ID: 11567046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ; Neve RL; Janowsky A; Neve KA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of dopaminergic neurotransmitter phenotype in rat embryonic cerebrocortex by the synergistic action of neurotrophins and dopamine.
    Zhou J; Bradford HF; Stern GM
    Eur J Neurosci; 1996 Nov; 8(11):2328-39. PubMed ID: 8950097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M; Maruyama W; Nagy GM
    Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
    Maruyama W; Boulton AA; Davis BA; Dostert P; Naoi M
    J Neural Transm (Vienna); 2001; 108(1):11-24. PubMed ID: 11261742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine.
    Seitz G; Stegmann HB; Jäger HH; Schlude HM; Wolburg H; Roginsky VA; Niethammer D; Bruchelt G
    J Neurochem; 2000 Aug; 75(2):511-20. PubMed ID: 10899926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
    Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
    J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design and synthesis of a biotinylated dopamine transporter ligand for the purification and labeling of dopaminergic neurons.
    Zimmermann K; Hengerer B
    Bioorg Med Chem Lett; 1998 Feb; 8(3):261-6. PubMed ID: 9871666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography.
    Xing D; Chen P; Keil R; Kilts CD; Shi B; Camp VM; Malveaux G; Ely T; Owens MJ; Votaw J; Davis M; Hoffman JM; BaKay RA; Subramanian T; Watts RL; Goodman MM
    J Med Chem; 2000 Feb; 43(4):639-48. PubMed ID: 10691690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cocaine inhibits the release of MPP+ but not dopamine through the rat dopamine transporter.
    Kitayama S; Morita K; Dohi T
    Eur J Pharmacol; 1996 Aug; 309(1):107-9. PubMed ID: 8864700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.